Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(30%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
20%
Ph not_applicable
8
80%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (20.0%)
N/A8 (80.0%)

Trials by Status

unknown220%
completed550%
recruiting330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10